Ovid Therapeutics
OVID
OVID
47 hedge funds and large institutions have $16.5M invested in Ovid Therapeutics in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
61% less capital invested
Capital invested by funds: $41.9M → $16.5M (-$25.4M)
Holders
47
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.87M | |
| 2 | +$348K | |
| 3 | +$192K | |
| 4 |
Renaissance Technologies
New York
|
+$133K |
| 5 |
Two Sigma Investments
New York
|
+$114K |
Top Sellers
| 1 | -$5.76M | |
| 2 | -$2.41M | |
| 3 | -$1.26M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.2M |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$634K |